Where you are...

Guideline Resource Info & Algorithm
...................................


IBS Guideline Resource Kit
Introduction
Guideline Resource Info & Algorithm
Info for Patients & Clinicians
The Science
Implementation Tips
Impact Assessment
Delfini Evidence & Usability Scale
(Use BACK to return from the scale)
Website Map

Downloads
Introduction [PDF]
Guideline Resource Information & Algorithm [PDF]
Information for Patients & Clinicians
[PDF]
The Science: Treatment
[PDF]
The Science: Diagnosis
[PDF]
The Science: Communications
[PDF]
Implementation Tips [PDF]
Impact Assessment Template [Excel]

...................................
Return to Delfini Main Menu

 


“EXPLICIT" EVIDENCE-BASED CLINICAL PRACTICE GUIDELINE RESOURCE KIT
Irritable Bowel Syndrome (IBS)

Original March 2003
Updates —

  • 07/06: Herbal Preparations
  • 04/07: Medication Withdrawal
THE SCIENCE
References
Systematic Reviews
Delfini Evidence & Usability Scale — (Use BACK to return from the scale)
Evidence-based Medicine (EBM) for consumers —
     Using Scientific Information in Medicine — About the principles and processes we used to analyze this information

References

1. Evidence-based position statement on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002 Nov;97(11 Suppl):S1-5).

2. Brandt LJ, Bjorkman D, Fennerty MB et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002 Nov;97(11 Suppl):S7-26).

3. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J. 1978 Sep 2;2(6138):653-4.

4. Thompson WG, Irvine EJ, Pare P et al. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci. 2002 Jan;47(1):225-35.

5. Olden KW. Diagnosis of irritable bowel syndrome. Gastroenterology 2002 May;122(6):1701-14.

6. Vanner SJ, Depew WT, Paterson WG, et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome.Am J Gastroenterol. 1999 Oct;94(10):2912-7.

7. Chey WD, Olden K, Carter E et al. Utility of the Rome I and Rome II criteria for irritable bowel syndrome in U.S. women. Am J Gastroenterol 2002 Nov;97(11):2803-11.

8. Stewart MA. Effective Physician-Patient Communication and Health Outcomes: A Review CMAJ 1995.152:1423-1433.

9. Hall JA; Roter DL; Katz NR. Meta-analysis of correlates of provider behavior in medical encounters. Medical Care;1988, 26:657-675.

10. Beck RS, Daughtridge R, Sloane PD. Physician-Patient Communication in the Primary Care Office: A Systematic Review. JABFP 2002. 15:25-38. The Journal of the American Board of Family Practice

11. Cash BD, Schoenfeld P, Chey WD. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol. 2002 Nov;97(11):2812-9.

12. Sanders DS, Carter MJ, Hurlstone DP, et al. Association of adult coeliac disease with irritable bowel syndrome: A case-control study in patients fulfilling the ROME II criteria referred to secondary care. Lancet 2001;358:1504-8.

13. Camilleri, M, Chey, WY, Mayer, EA, et al. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome. Arch Intern Med 2001; 161:1733.

14. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997 Jun;112(6):2120-37.

15. Mitchell CM, Drossman DA. Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology. 1987 May;92(5 Pt 1):1282-4.

16. Friedman, G. Diet and the irritable bowel syndrome. Gastroenterol Clin North Am 1991; 20:313.

17. Kaplan MA, Prior MJ, Ash RR et al. Loperamide-simethicone vs loperamide alone, simethicone alone, and placebo in the treatment of acute diarrhea with gas-related abdominal discomfort. A randomized controlled trial. Arch Fam Med 1999 May-Jun;8(3):243-8.

18. Lustman F, Walters EG, Shroff NE, et al. Diphenoxylate hydrochloride (Lomotil) in the treatment of acute diarrhoea. Br J Clin Pract. 1987 Mar;41(3):648-51.

19. Harford WV, Krejs GJ, Santa Ana CA et al. Acute effect of diphenoxylate with atropine (Lomotil) in patients with chronic diarrhea and fecal incontinence. Gastroenterology. 1980 Mar;78(3):440-3.

20. Talley NJ, Phillips SF, Mulvihill C et al. Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut 1990 Jan:31 (1):77-81.

21. Gatto NM, Frucht H, Sundararajan V, et al. Risk of Perforation After Colonoscopy and Sigmoidoscopy: A Population-based Study. J Natl Cancer Inst 2003; 95:230-6.

22. Madisch A, Holtmann G, Plein K, Hotz J. Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial. Aliment Pharmacol Ther 2004; 19: 271–279.

Systematic Reviews

Reference PDF
Treatment
2. Brandt LJ, Bjorkman D, Fennerty MB et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002 Nov;97(11 Suppl):S7-26). Brandt
Diagnosis
11. Cash BD, Schoenfeld P, Chey WD. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol. 2002 Nov;97(11):2812-9. Cash
Communications
10. Beck RS, Daughtridge R, Sloane PD. Physician-Patient Communication in the Primary Care Office: A Systematic Review. JABFP 2002. 15:25-38. The Journal of the American Board of Family Practice. Beck



 

Return IBS Introduction Page
Return Return Delfini Main Menu

© Delfini Group, LLC, 2002-2008. All Rights Reserved Worldwide.
Use of this website implies your agreement to our Notices »

Counter courtesy of www.amazingcounters.com and sponsors below: